Oklahoma Treatment Services LLC

Oklahoma Treatment Services LLC was paid $8.23M by Medicaid between Dec 2019 and Dec 2024, across 18 billing codes. Its largest line is S0109, Methadone, oral, 5 mg — 76% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	16	$410.53
2020	246	$8K
2021	62,813	$227K
2022	346,188	$2.52M
2023	374,404	$2.99M
2024incomplete	284,411	$2.48M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
S0109	Methadone, oral, 5 mg	76%	987,818	39,590	$6.25M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	5.4%	8,378	7,950	$443K
T1017	Case management, billed per 15 minutesTargeted case management, each 15 minutes	5.3%	36,343	19,028	$433K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	4.3%	5,457	5,235	$356K
H0004	Behavioral health counseling and therapy, per 15 minutes	2.1%	6,764	4,324	$171K
H0032	Mental health service plan development by non-physician	1.8%	2,323	2,288	$148K
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	1.4%	6,756	338	$115K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	1.3%	828	821	$108K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	<1%	365	365	$53K
84703		<1%	7,075	6,726	$42K
H0031	Mental health assessment, by non-physician	<1%	294	293	$30K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,326	657	$26K

6 more codes

H2015	Community support for mental illness or disability, per 15 minutes	<1%	1,568	$17K
J0575	Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine	<1%	890	$16K
J0571	Buprenorphine, oral, 1 mg	<1%	1,051	$11K
J0572	Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine	<1%	653	$7K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	121	$5K
86485		<1%	68	$2K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTHOMAS, KORDARYL (EXECUTIVE DIRECTOR)